Log In
Print
BCIQ
Print
Print this Print this
 

AC-201

  Manage Alerts
Collapse Summary General Information
Company TWi Pharmaceuticals Holding Inc.
DescriptionSmall molecule that modulates the transcription of IL-1 beta and IL-1RA
Molecular Target Interleukin-1 (IL-1) beta ; Interleukin-1 (IL-1) receptor antagonist (IL-1RA)
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationDiabetes
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today